Share
Share
Dr. Robert M. Merion, MD, FACS has announced that he will step down as President and Chief Executive Officer of Arbor Research Collaborative for Health by August 2021. The Arbor Research Board of Directors has appointed a Search Committee to lead the recruitment efforts for a successor. The position opportunity can be found on the Arbor Research careers page. Following the transition, Dr. Merion will remain on staff as a member of the scientific team.
January 8, 2025 — Christopher Spera, President and CEO of Arbor Research Collaborative for Health, announced the election of Bryan K. Johnson, JD, MBA to the Arbor Research board of directors in 2025. Mr. Johnson was a co-founder of Insight Policy Research in 2001. His strategic development, operational management, and financial oversight led the start-up
December 5, 2024 — Arbor Research Collaborative for Health is proud to announce an innovative collaboration with the Nephrology Associates of Northern Illinois and Indiana (NANI), the largest private nephrology practice in the United States. This partnership marks a significant milestone in advancing chronic kidney disease (CKD) research and management by leveraging NANI’s extensive patient-level
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen